Fujifilm Announces Commercialization of New Colonoscope Designed for Improved Polyp Detection and Control During Colonoscopy

March 30, 2021 - FUJIFILM Medical Systems U.S.A., Inc. - a leading provider of endoscopic and endosurgical technologies, today announced the launch of its new G-EYE^® 700 Series Colonoscope (G-EYE). G-EYE was developed in partnership with Smart Medical to improve visibility, stabilization and control during routine examinations. G-EYE has been shown to improve polyp detection compared to standard colonoscopy, reduce resection time for large lesions, and also may improve procedural efficiency for patients with challenging anatomy.
 
“Even the most skilled endoscopists face procedural challenges as a result of their patients’ unique and individual anatomies, making it difficult to provide a complete examination,” said Taisuke Fujita, General Manager Endoscopy, FUJIFILM Medical Systems U.S.A., Inc. “Together with Smart Medical, we’re excited to deliver endoscopists a solution that improves their ability to visualize hidden and hard-to-see polyps throughout the entire colon.”
 
G-EYE will be offered as an extension to the in-market 700-series colonoscope family, with a permanently integrated balloon at the bending section of the colonoscope.  The innovative design of the Fujifilm colonoscope is otherwise unchanged, and insertion can be performed as usual with the balloon deflated. On demand, the reusable balloon can be inflated to flatten the colonic walls, stabilize the scope in the center of the lumen, and increase the field of view during examination, thereby improving visualization of the mucosal surface and enabling detection of hidden or hard-to-see polyps. Stabilization of the endoscope also allows for a more controlled withdrawal and can be beneficial during therapy, potentially reducing resection time for large or difficult polyps.
 
Improved visualization with G-EYE is further enhanced by Fujifilm’s ELUXEO^® endoscopic video imaging system. When used with ELUXEO’s Linked Color Imaging (LCI^®) mode - an image enhancement tool that increases the contrast to improve detection of lesions and enable more accurate delineation - clinicians can expect to see an increase in their detection rate.
 
G-EYE is currently in use at New York University (NYU) Langone, and is being evaluated at Brigham and Women’s Hospital.
 
“We are excited to be one of the first centers in the country evaluating this innovative technology,” said Dr. Linda Lee, Medical Director of Endoscopy at Brigham and Women’s Hospital. “The G-EYE system was implemented seamlessly for everyday use, and early feedback from our physicians has indicated a number of promising benefits, including improved stability and visualization during withdrawal.”
 
Installation at other leading academic hospitals and a number of key ambulatory surgery centers will occur in the coming weeks.
 
Contact your Fujifilm representative or submit a request here to learn more about G-EYE.
 
About Fujifilm
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of innovative diagnostic imaging products and medical informatics solutions that meet and exceed the evolving needs of healthcare facilities today and into the future. It’s ever expanding medical imaging solutions span digital radiography (DR), detectors, portables and suites, mammography systems with digital breast tomosynthesis, computed tomography solutions for oncology and radiology applications, technologically advanced flexible and surgical endoscopy and fluoroscopy solutions. Fujifilm enables interoperability through its Systems Integration offering as well as its comprehensive, AI-supported Synapse® Enterprise Imaging portfolio, which includes the TeraMedica Division of Fujifilm. Fujifilm’s in vitro diagnostics (IVD) portfolio includes clinical lab reagents, and biomarkers to assess the risk for the development of hepatocellular carcinoma in patients with chronic liver disease. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit www.fujifilmhealthcare.com.

FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2020, the company had global revenues of $22.1 billion, at an exchange rate of 109 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
 

Contact Information

Danielle Brown

Senior Marketing Communications Manager

Fujifilm

Contact via E-mail